⚠
SpinalDose
NON-OBSTETRIC
🌙
LV
EN
BMI: 26.0
⚕
—
—
—
mg
—
—
—
—
—
—
—
—
—
—
—
—
—
Lee S et al. · Scientific Reports 2021 · n=401 · R²=0.72
EN
observational
Level
(segments from S5)
=
7.12
+
0.88
×
dose
(mg)
+
1.59
×
sex
← ♀=1, ♂=0
−
0.11
×
(
height
−
162
) cm
+
0.05
×
(
weight
−
68
) kg
+
K_age
K_age
: <
75
yr →
+0.00
|
75–85
yr →
+0.95
| >
85
yr →
+2.57
Harten JM et al. · Anaesthesia 2005 · RCT
EN
RCT
Volume
(ml, 0.5% hyperbaric bupivacaine) =
1.0
+
(
height
−
150
)
×
0.009
+
(
weight
−
50
)
×
0.003
Dose
(mg) = Volume
×
5
Piemērs / Example: 165 cm, 75 kg:
=
1.0
+
0.135
+
0.075
=
1.21 ml → 6.05 mg
Carpenter RL et al. · Anesthesiology 1992 · n=952
EN
observational
Dose
(mg) =
K
×
height
(cm)
K
by target level: S2–S5 →
0.05
| T10 →
0.07
T6 →
0.09
| T4 →
0.10
Piemērs: 170 cm, T10: 170 × 0.07 = 11.9 mg
SFAR · SEDAR · Miller's Anesthesia 9th ed. · Expert consensus
EN
ES
FR
consensus
Final dose
=
Base dose
×
K_age
×
K_height
×
K_BMI
×
K_sex
K_age
: <
60
yr →
×1.00
|
60–70
→
×0.85
|
70–80
→
×0.75
| >
80
→
×0.65
K_height
: <
150
cm →
×0.80
|
150–160
→
×0.90
|
160–175
→
×1.00
| >
175
→
×1.10
K_BMI
: <
25
→
×1.00
|
25–35
→
×0.90
| >
35
→
×0.80
K_sex
: Male / Vīrietis →
×1.00
| Female / Sieviete →
×0.93
Piemērs: 75 g.v. (×0.75) · 155 cm (×0.90) · ĶMI 30 (×0.90) → K = 0.608
Base 12 mg × 0.608 = 7.3 mg
Stienstra R, Greene NM · Regional Anesthesia 1991
EN
consensus
Dose
(mg) =
K_seg
×
n_segments
n_segments
= injection level − target level L3–L4 → T6: 17 − 6 =
11
segments
K_seg
: Hyperbaric bupi →
0.10–0.12
mg/segment Isobaric bupi →
0.12–0.15
mg/segment
Carpenter RL · Anesthesiology 1998 · MRI study
EN
observational
Lumbosacral CSF volume:
28–81 ml
(median
~45 ml
) LA concentration
∝
1
/ CSF_volume Factors reducing CSF volume: Obesity (BMI >
30
) → −
10–15 ml
Pregnancy → −
15–20 ml
Age >
70
yr → −
5–10 ml
Lumbar stenosis → −
10–25 ml
S2–S5
T10
T6
T4
TNS
Hyperbaric bupivacaine
0.5% / 8% dextrose
4–6 mg
0.8–1.2 ml
7.5–12.5 mg
1.5–2.5 ml
10–13 mg
2.0–2.6 ml
12–15 mg
2.4–3.0 ml
3–5 min
90–150 min
<1%
Isobaric bupivacaine
0.5% plain
—
10–15 mg
2.0–3.0 ml
12–17.5 mg
2.4–3.5 ml
15–20 mg
3.0–4.0 ml
5–8 min
120–180 min
<1%
Levobupivacaine
0.5% isobaric
—
10–12.5 mg
12–15 mg
12.5–17.5 mg
3–5 min
90–150 min
<1%
Ropivacaine
0.5–0.75% isobaric
—
15–17.5 mg
17.5–20 mg
20–22.5 mg
4–6 min
90–120 min
<1%
Hyperbaric prilocaine
2%
10–30 mg
0.5–1.5 ml
40–50 mg
2.0–2.5 ml
50–60 mg
2.5–3.0 ml
≤60 mg max
3–4 min
60–90 min
<1%
2-Chloroprocaine
1% preservative-free
20–30 mg
30–40 mg
40–50 mg
≤60 mg
3–5 min
40–60 min
~0%
Lidocaine
2–5% hyperbaric
25–30 mg
50–60 mg
60–75 mg
75–100 mg
max 100 mg
2–3 min
60–90 min
10–40%
Mepivacaine
1.5–2% isobaric
—
45–52 mg
52–60 mg
≤60 mg
3–5 min
90–120 min
6–8%
Fentanyl
10–25 µg
+30–60 min
2–4 h
Sufentanil
2.5–5 µg
+30–60 min
2–4 h
Morphine
KS: 100 µg
Liela ķir.: 100–300 µg
Max 300–500 µg
18–24 h
Clonidine
15–75 µg
(parasti 30–45 µg)
+45–75 min
4–6 h
Dexmedetomidine
3–10 µg
(opt: 5 µg)
+120–180 min
6–8 h